News and Updates

Nearly 80 percent of people with type 1 diabetes (T1D) fail to meet HbA1c goals defined by the American Diabetes Association. Despite more widely adopted diabetes technology and an increase in use, there is no improvement in clinical outcomes. This tells us that the current use of insulin alone is not enough, but vTv Therapeutics […]

Several decades ago, type 1 diabetes (T1D) patients brought their seeing-eye dogs into the offices where Jennifer Sun, M.D., MPH., now works. The complications of T1D had severely compromised or cost the patients their eyesight. Today, work led by Dr. Sun is changing all that. We share Dr. Sun’s work as part of our Meet […]

Monika Niewczas is keenly focused on kidneys. Specifically, making sure that they don’t stop working when someone develops type 1 diabetes (T1D). Niewczas, an M.D., Ph.D. and M.P.H., works as an assistant investigator at Joslin Diabetes Center and an assistant professor of medicine at Harvard Medical School. For the past 15 years, she has worked […]

It’s Autoimmune Disease Awareness Month, but what are autoimmune diseases? Good question. They occur when a person’s immune system mistakenly attacks another part of the person’s own body. This response can result in a range of diseases, depending on which parts of the body are affected. Research funded by Breakthrough T1D in the 1970s and […]

I’ve just gotten back from the 12th Network for Pancreatic Organ Donors with Diabetes (nPOD) Annual Meeting, which was held February 23-26, 2020, and featured some of the most world-renowned diabetes investigators. nPOD is now the world’s largest tissue bank dedicated to the study of the human pancreas in type 1 diabetes (T1D), and the […]

Cost for each diagnosed American is nearly $500,000.

Each year diabetes researchers from all over the world gather for the annual meeting of the Advanced Technologies & Treatments for Diabetes (ATTD), which this year took place on February 19-22 in Madrid, Spain. Many of the latest advances will be discussed, including research that Breakthrough T1D has funded to advance new breakthroughs and therapies […]

Ellen Leake, Chair of the International Board of Directors

Breakthrough T1D is honored to recognize five leading international researchers whose work has and is transforming type 1 diabetes (T1D) science. We also are proud that our funding has helped drive their work forward toward both curing type 1 diabetes and improving the lives of those living with the disease today. The recipient of the […]

A new study commissioned by the Breakthrough T1D T1D Fund spotlights the high economic burden of type 1 diabetes (T1D) and the tremendous value of accelerating disease-modifying therapies. The study, released today, estimates the annual cost of T1D is more than $30 billion in the United States, where 1.6 million people are living with the […]